In re Bayer Aktiengesellschaft, 2006-1279
In proceedings involving Bayer's efforts to register the mark "ASPIRINA" in connection with analgesic goods, a Trademark Trial and Appeal Board ruling that the proposed mark "ASPIRINA" was merely descriptive for analgesic goods is affirmed as the ruling was supported by substantial evidence.
- Decided 05/24/2007
- Published 05/25/2007
Before NEWMAN, SCHALL, and MOORE, Circuit Judges.
United States Federal Circuit
Michael L. Lovitz, Connolly Bove Lodge & Hutz LLP, of Wilmington, DE, argued for appellant. With him on the brief were Stanley C. Macel, III, and Jennifer Fraser., Nancy C. Slutter, Associate Solicitor, United States Patent and Trademark Office, of Arlington, VA, argued for the Director of the United States Patent and Trademark Office. With her on the brief were John M. Whealan, Solicitor, and Robert J. McManus, Associate Solicitor.